Thywill Latam Solutions SRL   Report issue

For profit Phase 1
Founded: Buenos Aires Argentina (2003)
Status: No NME R&D (2003)

Organization Overview

First Clinical Trial
2007
NCT00432562
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 1 Trials (1)

vinorelbine (navelbine) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma, Non-Small-Cell Lung (Phase 1)

Lymphoma, Non-Hodgkin (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1